{"disease":{"id":"waldenstrom-macroglobulinaemia","name":"waldenstrom macroglobulinaemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04728893","title":"Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":490,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06550427","title":"Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07160270","title":"This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT06200220","title":"Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia","phase":"","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT00811733","title":"A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03679624","title":"Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}